Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon

Nearly 20% of new mothers struggle with anxiety or depression, a significant health concern that can affect both the mother and child. A promising new treatment involving psychedelics is making its way through FDA clinical trials, showing potential to alleviate these mental health issues. This treatment could revolutionize postpartum care by providing a much-needed alternative to traditional therapies, which often have limited effectiveness. If successful, it could greatly improve maternal mental health outcomes and help more new moms navigate this challenging period.